Boston Scientific Announces Results For Third Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Goldman Sachs to acquire real estate company LCN for up to $410M
Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr
October 24, 2018 12:52 PM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as revenue missed consensus due to currency while its EPS beat consensus. Meanwhile, management lowered its revenue guidance due to currency and narrowed its EPS guidance.
Matson... More
Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
October 24, 2018 6:33 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Boston Scientific sees FY2018 EPS of $1.38-$1.40, versus the consensus of $1.40.... More
